Vault-13

ADAR1 Capital Management, LLC

AUSTIN, TX · CIK 1940272 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2024 · limited liability company

$2.1bn reported value +27.9% vs Q1 2026
267positions
41.9%in top 10
45 new 96 added 64 reduced 72 sold out vs Q1 2026

Options: 6 call positions ($8.8m notional), 4 put positions ($48.8m notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ABIVAX SA SPONSORED ADS ABVX ABVX 1,804,703 $240.5m11.30% 11.30% AddedShares held: Q3 2025 1.4m, Q4 2025 1.3m, Q1 2026 1.4m, Q2 2026 1.8m +410.7k +410,684 29.5%
2 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 960,863 $117.8m5.54% 5.54% ReducedShares held: Q3 2025 989.2k, Q4 2025 1.0m, Q1 2026 994.1k, Q2 2026 960.9k -33.3k -33,256 -3.4%
3 ROIVANT SCIENCES LTD SHS ROIV ROIV 3,157,008 $111.7m5.25% 5.25% ReducedShares held: Q3 2025 3.3m, Q4 2025 3.4m, Q1 2026 3.3m, Q2 2026 3.2m -128.9k -128,898 -3.9%
4 SPDR S&P 500 ETF TR TR UNIT SPY SPY 129,087 $96.4m4.53% 4.53% AddedShares held: Q3 2025 54.7k, Q4 2025 54.7k, Q1 2026 75.9k, Q2 2026 129.1k +53.1k +53,147 70.0%
5 IMMUNOVANT INC COM IMVT IMVT 2,330,716 $89.8m4.22% 4.22% ReducedShares held: Q3 2025 2.2m, Q4 2025 2.5m, Q1 2026 2.7m, Q2 2026 2.3m -348.3k -348,294 -13.0%
6 ZAI LAB LTD ADR ZLAB ZLAB 3,369,034 $64.0m3.01% 3.01% AddedShares held: Q3 2025 868.8k, Q4 2025 1.2m, Q1 2026 1.4m, Q2 2026 3.4m +1.9m +1,943,667 136.4%
7 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 1,288,053 $47.8m2.25% 2.25% AddedShares held: Q3 2025 37.0k, Q4 2025 188.0k, Q1 2026 140.7k, Q2 2026 1.3m +1.1m +1,147,381 815.6%
8 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 1,222,080 $45.7m2.15% 2.15% AddedShares held: Q3 2025 248.4k, Q4 2025 309.4k, Q1 2026 1.1m, Q2 2026 1.2m +82.7k +82,749 7.3%
9 EA SERIES TRUST ALPHA ARCH 1-3 BOXX BOXX 337,125 $39.5m1.86% 1.86% UnchangedShares held: Q3 2025 337.1k, Q4 2025 337.1k, Q1 2026 337.1k, Q2 2026 337.1k
10 CYTOKINETICS INC COM NEW CYTK CYTK 457,907 $39.0m1.83% 1.83% ReducedShares held: Q3 2025 518.9k, Q4 2025 540.2k, Q1 2026 632.6k, Q2 2026 457.9k -174.6k -174,649 -27.6%
11 SEPTERNA INC COM SEPN SEPN 940,747 $31.5m1.48% 1.48% ReducedShares held: Q3 2025 1.2m, Q4 2025 1.2m, Q1 2026 1.1m, Q2 2026 940.7k -149.1k -149,071 -13.7%
12 ANTERIS TECHNOLOGIES GLOBAL COM AVR AVR 3,145,096 $31.0m1.46% 1.46% ReducedShares held: Q3 2025 197.6k, Q4 2025 1.2m, Q1 2026 3.8m, Q2 2026 3.1m -644.0k -644,036 -17.0%
13 EDITAS MEDICINE INC COM EDIT EDIT 8,889,000 $28.8m1.35% 1.35% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 8.9m
14 DENALI THERAPEUTICS INC COM DNLI DNLI 1,029,080 $26.5m1.24% 1.24% ReducedShares held: Q3 2025 51.5k, Q4 2025 52.1k, Q1 2026 1.9m, Q2 2026 1.0m -842.4k -842,375 -45.0%
15 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 283,982 $25.2m1.19% 1.19% ReducedShares held: Q3 2025 34.1k, Q4 2025 34.1k, Q1 2026 338.3k, Q2 2026 284.0k -54.3k -54,341 -16.1%
16 VIR BIOTECHNOLOGY INC COM VIR VIR 2,456,677 $25.0m1.18% 1.18% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.7m, Q2 2026 2.5m -288.0k -288,037 -10.5%
17 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 74,253 $24.9m1.17% 1.17% AddedShares held: Q3 2025 0, Q4 2025 1.5k, Q1 2026 1.5k, Q2 2026 74.3k +72.8k +72,753 4850.2%
18 INSMED INC COM PAR $.01 INSM INSM 228,520 $24.4m1.15% 1.15% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 35.4k, Q2 2026 228.5k +193.1k +193,128 545.7%
19 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 619,542 $23.1m1.08% 1.08% AddedShares held: Q3 2025 109.4k, Q4 2025 646.8k, Q1 2026 427.8k, Q2 2026 619.5k +191.7k +191,726 44.8%
20 VIKING THERAPEUTICS INC COM VKTX VKTX 574,038 $22.4m1.05% 1.05% AddedShares held: Q3 2025 175.9k, Q4 2025 26.5k, Q1 2026 227.7k, Q2 2026 574.0k +346.3k +346,321 152.1%
21 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 3,040,466 $20.7m0.97% 0.97% AddedShares held: Q3 2025 2.8m, Q4 2025 2.5m, Q1 2026 3.0m, Q2 2026 3.0m +61.0k +61,037 2.0%
22 MONOPAR THERAPEUTICS INC COM NEW MNPR MNPR 217,595 $20.1m0.95% 0.95% ReducedShares held: Q3 2025 130.0k, Q4 2025 233.9k, Q1 2026 264.3k, Q2 2026 217.6k -46.7k -46,683 -17.7%
23 OVID THERAPEUTICS INC COM OVID OVID 7,417,479 $20.0m0.94% 0.94% AddedShares held: Q3 2025 12.8k, Q4 2025 4.3m, Q1 2026 4.5m, Q2 2026 7.4m +2.9m +2,873,366 63.2%
24 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 387,718 $19.7m0.92% 0.92% AddedShares held: Q3 2025 0, Q4 2025 30.0k, Q1 2026 329.5k, Q2 2026 387.7k +58.2k +58,178 17.6%
25 ENANTA PHARMACEUTICALS INC COM ENTA ENTA 1,344,510 $19.6m0.92% 0.92% AddedShares held: Q3 2025 0, Q4 2025 41.4k, Q1 2026 51.4k, Q2 2026 1.3m +1.3m +1,293,153 2518.0%
26 NEKTAR THERAPEUTICS COM NEW NKTR NKTR 244,184 $17.0m0.80% 0.80% AddedShares held: Q3 2025 72.0k, Q4 2025 72.0k, Q1 2026 161.3k, Q2 2026 244.2k +82.9k +82,932 51.4%
27 INSPIRE MED SYS INC COM INSP INSP 374,617 $16.7m0.79% 0.79% ReducedShares held: Q3 2025 6.0k, Q4 2025 15.0k, Q1 2026 405.2k, Q2 2026 374.6k -30.6k -30,580 -7.5%
28 REVOLUTION MEDICINES INC COM RVMD RVMD 87,509 $16.4m0.77% 0.77% ReducedShares held: Q3 2025 139.1k, Q4 2025 145.1k, Q1 2026 133.9k, Q2 2026 87.5k -46.4k -46,384 -34.6%
29 ESTABLISHMENT LABS HLDGS INC COM ESTA ESTA 185,619 $15.9m0.75% 0.75% ReducedShares held: Q3 2025 90.7k, Q4 2025 171.4k, Q1 2026 213.5k, Q2 2026 185.6k -27.9k -27,854 -13.1%
30 PROTHENA CORP PLC SHS PRTA PRTA 1,554,535 $15.2m0.72% 0.72% ReducedShares held: Q3 2025 1.5m, Q4 2025 1.5m, Q1 2026 1.6m, Q2 2026 1.6m -26.9k -26,908 -1.7%
31 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 136,158 $15.1m0.71% 0.71% ReducedShares held: Q3 2025 49.6k, Q4 2025 51.3k, Q1 2026 211.4k, Q2 2026 136.2k -75.3k -75,292 -35.6%
32 INHIBIKASE THERAPEUTICS INC COM NEW IKT IKT 7,387,205 $15.0m0.70% 0.70% AddedShares held: Q3 2025 5.2m, Q4 2025 8.1m, Q1 2026 6.6m, Q2 2026 7.4m +780.6k +780,633 11.8%
33 UNIQURE NV SHS QURE QURE 324,672 $15.0m0.70% 0.70% AddedShares held: Q3 2025 133.3k, Q4 2025 235.2k, Q1 2026 76.2k, Q2 2026 324.7k +248.5k +248,466 326.1%
34 RALLYBIO CORP COM RLYB RLYB 926,352 $14.8m0.70% 0.70% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 20.5k, Q2 2026 926.4k +905.8k +905,817 4411.1%
35 REGENERON PHARMACEUTICALS COM REGN REGN 22,208 $13.8m0.65% 0.65% AddedShares held: Q3 2025 15.7k, Q4 2025 12.1k, Q1 2026 12.2k, Q2 2026 22.2k +10.1k +10,054 82.7%
36 INVENTIVA SA ADS IVA IVA 3,606,656 $13.6m0.64% 0.64% AddedShares held: Q3 2025 0, Q4 2025 2.7m, Q1 2026 2.2m, Q2 2026 3.6m +1.4m +1,432,258 65.9%
37 SUTRO BIOPHARMA INC COM SHS STRO STRO 404,014 $13.4m0.63% 0.63% ReducedShares held: Q3 2025 0, Q4 2025 67.1k, Q1 2026 524.4k, Q2 2026 404.0k -120.4k -120,427 -23.0%
38 IONIS PHARMACEUTICALS INC COM IONS IONS 166,286 $13.2m0.62% 0.62% AddedShares held: Q3 2025 133.8k, Q4 2025 147.1k, Q1 2026 160.3k, Q2 2026 166.3k +5.9k +5,948 3.7%
39 BRIDGEBIO PHARMA INC COM BBIO BBIO 176,689 $13.2m0.62% 0.62% AddedShares held: Q3 2025 273.4k, Q4 2025 213.4k, Q1 2026 94.3k, Q2 2026 176.7k +82.4k +82,397 87.4%
40 SAREPTA THERAPEUTICS INC COM SRPT SRPT 730,649 $13.1m0.62% 0.62% AddedShares held: Q3 2025 349.8k, Q4 2025 28.9k, Q1 2026 262.1k, Q2 2026 730.6k +468.6k +468,591 178.8%
41 CYTOMX THERAPEUTICS INC COM CTMX CTMX 3,365,118 $12.6m0.59% 0.59% ReducedShares held: Q3 2025 4.0m, Q4 2025 4.2m, Q1 2026 3.4m, Q2 2026 3.4m -45.1k -45,072 -1.3%
42 VOR BIOPHARMA INC COM NEW VOR VOR 680,626 $12.5m0.59% 0.59% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 680.6k
43 SPDR SER TR BLOOMBERG 1-3 MO BIL BIL 135,585 $12.4m0.58% 0.58% UnchangedShares held: Q3 2025 135.6k, Q4 2025 135.6k, Q1 2026 135.6k, Q2 2026 135.6k
44 EQUILLIUM INC COM EQ EQ 3,758,569 $12.0m0.57% 0.57% AddedShares held: Q3 2025 5.6m, Q4 2025 5.6m, Q1 2026 3.7m, Q2 2026 3.8m +31.9k +31,910 0.9%
45 ADLAI NORTYE LTD SPONSORED ADS ANL ANL 1,017,805 $11.7m0.55% 0.55% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 117.9k, Q2 2026 1.0m +899.9k +899,896 763.2%
46 CLIMB BIO INC COM CLYM CLYM 822,649 $10.7m0.50% 0.50% AddedShares held: Q3 2025 133.5k, Q4 2025 1.4m, Q1 2026 597.7k, Q2 2026 822.6k +225.0k +224,987 37.6%
47 HELIX ACQUISITION CORP III USD CL A ORD SHS HLXC HLXC 1,000,000 $10.6m0.50% 0.50% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.0m, Q2 2026 1.0m
48 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 1,759,295 $10.4m0.49% 0.49% AddedShares held: Q3 2025 652.2k, Q4 2025 562.1k, Q1 2026 630.4k, Q2 2026 1.8m +1.1m +1,128,892 179.1%
49 ONKURE THERAPEUTICS INC COM CL A OKUR OKUR 2,238,684 $10.2m0.48% 0.48% ReducedShares held: Q3 2025 0, Q4 2025 1.0m, Q1 2026 2.4m, Q2 2026 2.2m -196.3k -196,257 -8.1%
50 MAZE THERAPEUTICS INC COM MAZE MAZE 339,276 $10.1m0.48% 0.48% AddedShares held: Q3 2025 26.0k, Q4 2025 179.5k, Q1 2026 50.1k, Q2 2026 339.3k +289.2k +289,181 577.3%
51 XENON PHARMACEUTICALS INC COM XENE XENE 166,550 $10.1m0.47% 0.47% ReducedShares held: Q3 2025 189.1k, Q4 2025 204.0k, Q1 2026 228.9k, Q2 2026 166.6k -62.3k -62,349 -27.2%
52 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 277,848 $9.4m0.44% 0.44% AddedShares held: Q3 2025 267.8k, Q4 2025 236.0k, Q1 2026 268.4k, Q2 2026 277.8k +9.5k +9,457 3.5%
53 UROGEN PHARMA LTD COM URGN URGN 252,395 $9.3m0.44% 0.44% ReducedShares held: Q3 2025 35.0k, Q4 2025 125.4k, Q1 2026 395.5k, Q2 2026 252.4k -143.1k -143,064 -36.2%
54 FAETH THERAPEUTICS INC COM NEW FTH FTH 361,010 $9.0m0.42% 0.42% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 361.0k
55 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 494,378 $8.9m0.42% 0.42% ReducedShares held: Q3 2025 866.2k, Q4 2025 890.4k, Q1 2026 1.0m, Q2 2026 494.4k -506.2k -506,226 -50.6%
56 DBV TECHNOLOGIES S A SPONSORED ADS DBVT DBVT 528,295 $8.7m0.41% 0.41% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.0m, Q2 2026 528.3k -484.6k -484,571 -47.8%
57 SAVARA INC COM SVRA SVRA 1,403,409 $8.6m0.41% 0.41% ReducedShares held: Q3 2025 2.0m, Q4 2025 1.4m, Q1 2026 1.5m, Q2 2026 1.4m -61.1k -61,126 -4.2%
58 VAXCYTE INC COM PCVX PCVX 146,034 $8.5m0.40% 0.40% ReducedShares held: Q3 2025 213.1k, Q4 2025 315.6k, Q1 2026 259.1k, Q2 2026 146.0k -113.1k -113,103 -43.6%
59 CG ONCOLOGY INC COM CGON CGON 118,664 $8.4m0.40% 0.40% ReducedShares held: Q3 2025 248.9k, Q4 2025 258.1k, Q1 2026 185.7k, Q2 2026 118.7k -67.0k -67,035 -36.1%
60 MINERALYS THERAPEUTICS INC COM MLYS MLYS 298,886 $8.1m0.38% 0.38% AddedShares held: Q3 2025 78.2k, Q4 2025 136.2k, Q1 2026 154.7k, Q2 2026 298.9k +144.2k +144,200 93.2%
61 ASCENDIS PHARMA A/S ORD SHS ASND ASND 28,604 $7.6m0.36% 0.36% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 28.6k
62 AMANAT ACQUISITION CORP CL A ORD AMAN AMAN 750,000 $7.6m0.36% 0.36% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 750.0k
63 NURIX THERAPEUTICS INC COM NRIX NRIX 313,236 $7.6m0.36% 0.36% AddedShares held: Q3 2025 31.2k, Q4 2025 72.1k, Q1 2026 56.1k, Q2 2026 313.2k +257.2k +257,166 458.6%
64 BIOHAVEN LTD COM BHVN BHVN 501,687 $7.5m0.35% 0.35% AddedShares held: Q3 2025 24.3k, Q4 2025 34.3k, Q1 2026 44.8k, Q2 2026 501.7k +456.9k +456,910 1020.4%
65 PRIME MEDICINE INC COM PRME PRME 1,997,552 $7.4m0.35% 0.35% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.0m, Q2 2026 2.0m +24.3k +24,270 1.2%
66 PERCEPTIVE CAP SOLUTIONS COR CL A ORD SHS FRNM FRNM 674,695 $7.3m0.35% 0.35% AddedShares held: Q3 2025 750.0k, Q4 2025 456.7k, Q1 2026 499.6k, Q2 2026 674.7k +175.1k +175,114 35.0%
67 OPUS GENETICS INC COM IRD IRD 1,783,781 $7.3m0.34% 0.34% ReducedShares held: Q3 2025 0, Q4 2025 40.0k, Q1 2026 1.8m, Q2 2026 1.8m -65.2k -65,223 -3.5%
68 LEXEO THERAPEUTICS INC COM LXEO LXEO 1,565,950 $7.3m0.34% 0.34% AddedShares held: Q3 2025 1.5m, Q4 2025 1.4m, Q1 2026 1.5m, Q2 2026 1.6m +98.6k +98,600 6.7%
69 DAMORA THERAPEUTICS INC COM NEW COM NEW 280,000 $7.3m0.34% 0.34% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 279.0k, Q2 2026 280.0k +1.0k +1,000 0.4%
70 REPLIMUNE GROUP INC COM REPL REPL 655,784 $7.3m0.34% 0.34% ReducedShares held: Q3 2025 978.9k, Q4 2025 1.2m, Q1 2026 1.6m, Q2 2026 655.8k -927.2k -927,203 -58.6%
71 LEONABIO INC COM LONA LONA 777,100 $7.1m0.34% 0.34% AddedShares held: Q3 2025 0, Q4 2025 393.7k, Q1 2026 727.5k, Q2 2026 777.1k +49.6k +49,619 6.8%
72 KORRO BIO INC COM KRRO KRRO 540,054 $7.1m0.33% 0.33% UnchangedShares held: Q3 2025 40.2k, Q4 2025 0, Q1 2026 540.1k, Q2 2026 540.1k
73 RESEARCH ALLIANCE CORP III ORD SHS CL A RACC RACC 650,000 $7.0m0.33% 0.33% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 650.0k
74 INFLARX NV COM IFRX IFRX 3,000,000 $6.7m0.32% 0.32% AddedShares held: Q3 2025 159.5k, Q4 2025 0, Q1 2026 158.3k, Q2 2026 3.0m +2.8m +2,841,729 1795.5%
75 RELAY THERAPEUTICS INC COM RLAY RLAY 358,333 $6.7m0.32% 0.32% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 358.3k
76 JANUX THERAPEUTICS INC COM JANX JANX 420,881 $6.5m0.30% 0.30% AddedShares held: Q3 2025 351.0k, Q4 2025 245.5k, Q1 2026 298.5k, Q2 2026 420.9k +122.3k +122,335 41.0%
77 PLIANT THERAPEUTICS INC COM PLRX PLRX 5,509,724 $6.3m0.30% 0.30% AddedShares held: Q3 2025 0, Q4 2025 73.8k, Q1 2026 2.6m, Q2 2026 5.5m +2.9m +2,924,598 113.1%
78 AADI BIOSCIENCE INC COM WHWK WHWK 1,341,394 $6.1m0.29% 0.29% AddedShares held: Q3 2025 0, Q4 2025 77.6k, Q1 2026 128.5k, Q2 2026 1.3m +1.2m +1,212,891 943.9%
79 KRYSTAL BIOTECH INC COM KRYS KRYS 16,420 $6.1m0.29% 0.29% ReducedShares held: Q3 2025 18.5k, Q4 2025 20.0k, Q1 2026 20.0k, Q2 2026 16.4k -3.6k -3,594 -18.0%
80 ARBUTUS BIOPHARMA CORP COM ABUS ABUS 1,268,147 $6.1m0.29% 0.29% ReducedShares held: Q3 2025 2.9m, Q4 2025 5.4m, Q1 2026 3.1m, Q2 2026 1.3m -1.9m -1,865,028 -59.5%
81 PFIZER INC COM PFE PFE 252,400 $6.1m0.29% 0.29% AddedShares held: Q3 2025 44.4k, Q4 2025 72.4k, Q1 2026 77.4k, Q2 2026 252.4k +175.0k +175,000 226.1%
82 BRIGHTHOUSE FINL INC COM BHF BHF 95,523 $6.0m0.28% 0.28% UnchangedShares held: Q3 2025 10.0k, Q4 2025 95.5k, Q1 2026 95.5k, Q2 2026 95.5k
83 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 143,199 $5.8m0.27% 0.27% AddedShares held: Q3 2025 40.0k, Q4 2025 91.0k, Q1 2026 90.6k, Q2 2026 143.2k +52.6k +52,600 58.1%
84 ALECTOR INC COM ALEC ALEC 2,883,583 $5.8m0.27% 0.27% AddedShares held: Q3 2025 0, Q4 2025 1.1m, Q1 2026 1.1m, Q2 2026 2.9m +1.8m +1,833,583 174.6%
85 FULCRUM THERAPEUTICS INC COM FULC FULC 1,565,029 $5.7m0.27% 0.27% AddedShares held: Q3 2025 341.6k, Q4 2025 1.3m, Q1 2026 130.6k, Q2 2026 1.6m +1.4m +1,434,469 1098.7%
86 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 69,800 $5.7m0.27% 0.27% ReducedShares held: Q3 2025 49.8k, Q4 2025 58.2k, Q1 2026 70.3k, Q2 2026 69.8k -500 -500 -0.7%
87 ACUMEN PHARMACEUTICALS INC COM ABOS ABOS 2,111,334 $5.6m0.26% 0.26% ReducedShares held: Q3 2025 891.2k, Q4 2025 891.2k, Q1 2026 2.2m, Q2 2026 2.1m -45.0k -45,000 -2.1%
88 OAKTREE ACQUISITION CORP III UNIT 10/04/2029 OACCU OACCU 516,482 $5.6m0.26% 0.26% UnchangedShares held: Q3 2025 516.5k, Q4 2025 516.5k, Q1 2026 516.5k, Q2 2026 516.5k
89 GLOBUS MED INC CL A GMED GMED 70,100 $5.5m0.26% 0.26% AddedShares held: Q3 2025 0, Q4 2025 20.1k, Q1 2026 20.1k, Q2 2026 70.1k +50.0k +50,000 248.8%
90 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 216,752 $5.2m0.25% 0.25% AddedShares held: Q3 2025 215.8k, Q4 2025 215.8k, Q1 2026 215.8k, Q2 2026 216.8k +1.0k +1,000 0.5%
91 DISCIPLINED GROWTH UNIT 99/99/9999 DGAC.U DGAC.U 500,000 $5.0m0.24% 0.24% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 500.0k
92 BHAV ACQUISITION CORP UNIT 03/18/2031 BHAVU BHAVU 495,000 $5.0m0.24% 0.24% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 495.0k, Q2 2026 495.0k
93 BRIDGEBIO PHARMA INC NOTE 1.750% 3/0 · principal BBIO 1.75 03.01.31 · principal BBIO 1.75 03.01.31 30,000 $5.0m0.23% 0.23% UnchangedPrincipal held: Q3 2025 0, Q4 2025 0, Q1 2026 30.0k, Q2 2026 30.0k
94 BRIDGEBIO PHARMA INC NOTE 2.250% 2/0 · principal BBIO 2.25 02.01.29 · principal BBIO 2.25 02.01.29 45,000 $4.9m0.23% 0.23% UnchangedPrincipal held: Q3 2025 45.0k, Q4 2025 0, Q1 2026 45.0k, Q2 2026 45.0k
95 DANAHER CORPORATION COM DHR DHR 25,932 $4.9m0.23% 0.23% ReducedShares held: Q3 2025 0, Q4 2025 25.6k, Q1 2026 30.9k, Q2 2026 25.9k -5.0k -5,000 -16.2%
96 BOUNDLESS BIO INC COM BOLD BOLD 1,968,216 $4.9m0.23% 0.23% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.0m
97 AVALYN PHARMACEUTICALS INC COM SHS AVLN AVLN 146,447 $4.8m0.23% 0.23% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 146.4k
98 ARS PHARMACEUTICALS INC COM SPRY SPRY 600,999 $4.8m0.23% 0.23% ReducedShares held: Q3 2025 59.2k, Q4 2025 369.6k, Q1 2026 1.4m, Q2 2026 601.0k -760.5k -760,537 -55.9%
99 ATAIBECKLEY INC COM SHS ATAI ATAI 913,242 $4.8m0.23% 0.23% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 913.2k, Q2 2026 913.2k
100 PRELUDE THERAPEUTICS INC COM PRLD PRLD 900,900 $4.8m0.23% 0.23% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 152.8k, Q2 2026 900.9k +748.1k +748,075 489.5%

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
TERNS PHARMACEUTICALS INC 914,699 $48.2m914.7k shares
BEAM THERAPEUTICS INC BEAM BEAM 1,446,375 $34.5m1.4m shares
SCHOLAR ROCK HLDG CORP SRRK SRRK 407,273 $20.0m407.3k shares
VERTEX PHARMACEUTICALS INC VRTX VRTX 15,075 $6.7m15.1k shares
VIRIDIAN THERAPEUTICS INC VRDN VRDN 304,422 $6.0m304.4k shares
ASCENDIS PHARMA A/S 25,014 $5.7m25.0k shares
ELI LILLY & CO LLY LLY 5,060 $4.7m5.1k shares
DIANTHUS THERAPEUTICS INC DNTH DNTH 55,000 $4.6m55.0k shares
BELITE BIO INC BLTE BLTE 26,880 $4.3m26.9k shares
ARCELLX INC ACLX ACLX 32,084 $3.7m32.1k shares
ARRIVENT BIOPHARMA INC AVBP AVBP 141,814 $3.3m141.8k shares
APELLIS PHARMACEUTICALS INC APLS APLS 72,500 $2.9m72.5k shares
MASIMO CORP MASI MASI 15,000 $2.7m15.0k shares
TELEFLEX INCORPORATED TFX TFX 21,186 $2.5m21.2k shares
BIOAGE LABS INC BIOA BIOA 135,560 $2.4m135.6k shares
ALKERMES PLC ALKS ALKS 46,400 $1.6m46.4k shares
SOLENO THERAPEUTICS INC SLNO SLNO 46,830 $1.6m46.8k shares
CENTESSA PHARMACEUTICALS PLC 38,566 $1.5m38.6k shares
AMICUS THERAPEUTICS INC FOLD FOLD 105,000 $1.5m105.0k shares
UNITEDHEALTH GROUP INC UNH UNH 5,501 $1.5m5.5k shares
SENSIENT TECHNOLOGIES CORP SXT SXT 15,000 $1.3m15.0k shares
SCHRODINGER INC SDGR SDGR 101,500 $1.2m101.5k shares
4D MOLECULAR THERAPEUTICS IN FDMT FDMT 116,712 $1.1m116.7k shares
DAY ONE BIOPHARMACEUTICALS I 49,923 $1.1m49.9k shares
BRISTOL-MYERS SQUIBB CO BMY BMY 17,500 $1.1m17.5k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
ISHARES TR IWM · Put IWMPut 62,500 $18.8m62.5k shares Added
SPDR S&P 500 ETF TR SPY · Put SPYPut 25,000 $18.7m25.0k shares New
SPDR SER TR XBI · Put XBIPut 67,400 $10.7m67.4k shares Added
ABIVAX SA ABVX · Call ABVXCall 44,400 $5.9m44.4k shares Added
KEEN VISION ACQUISITION CORP KVACF · Call KVACFCall 75,000 $930.0k75.0k shares Unchanged
AMYLYX PHARMACEUTICALS INC AMLX · Put AMLXPut 40,100 $720.2k40.1k shares New
ULTRAGENYX PHARMACEUTICAL IN RARE · Call RARECall 20,000 $667.8k20.0k shares Unchanged
NOVO-NORDISK A S NVO · Call NVOCall 13,000 $623.2k13.0k shares Unchanged
CORBUS PHARMACEUTICALS HLDGS CRBP · Call CRBPCall 60,000 $562.8k60.0k shares Added
SOLIDION TECHNOLOGY INC STI · Call STICall 13,500 $125.4k13.5k shares Unchanged

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
RALLYBIO CORP RLYB · 13G · filed 2026-06-05 RLYB 17.5%≈ $14.8m new 13G 2026-06-05
INMED PHARMACEUTICALS INC INM · 13G · filed 2026-10-07 INM 17.2%≈ $971.9k -6.9 pts 13G 2026-10-07
NEXTCURE INC NXTC · 13G · filed 2026-08-14 NXTC 15.8%≈ $1.2m new 13G 2026-08-14
TENAX THERAPEUTICS INC TENX · 13G · filed 2026-09-08 TENX 14.0%≈ $76.5m new 13G 2026-09-08
GRACE THERAPEUTICS INC GRCE · 13G · filed 2026-08-14 GRCE 9.9%≈ $4.0m no change 13G 2026-08-14
KIORA PHARMACEUTICALS INC KPRX · 13G · filed 2026-08-14 KPRX 9.9%≈ $1.3m no change 13G 2026-08-14
INHIBIKASE THERAPEUTICS INC IKT · 13G · filed 2026-05-15 IKT 9.9%≈ $28.1m no change 13G 2026-05-15
EQUILLIUM INC EQ · 13G · filed 2026-05-15 EQ 9.9%≈ $21.1m no change 13G 2026-05-15
ACASTI PHARMA INC 13G · filed 2025-11-14 9.9% -0.1 pts 13G 2025-11-14
AMANAT ACQUISITION CORP AMAN · 13G · filed 2026-08-14 AMAN 9.6%≈ $7.6m new 13G 2026-08-14
PLIANT THERAPEUTICS INC PLRX · 13G · filed 2026-08-14 PLRX 8.9%≈ $6.3m new 13G 2026-08-14
BOUNDLESS BIO INC BOLD · 13G · filed 2026-08-14 BOLD 8.8%≈ $4.9m new 13G 2026-08-14
RESEARCH ALLIANCE CORP III RACC · 13G · filed 2026-08-14 RACC 8.4%≈ $7.0m new 13G 2026-08-14
LEONABIO INC LONA · 13G · filed 2026-05-15 LONA 7.7%≈ $6.7m new 13G 2026-05-15
CYCLERION THERAPEUTICS INC 13G · filed 2026-08-14 7.0%≈ $1.0m new 13G 2026-08-14
EDITAS MEDICINE INC EDIT · 13G · filed 2026-08-14 EDIT 5.8%≈ $28.8m new 13G 2026-08-14
HELIX ACQUISITION CORP III HLXC · 13G · filed 2026-05-15 HLXC 5.6%≈ $10.6m new 13G 2026-05-15
ADAGIO MED HLDGS INC ADGM · 13G · filed 2026-08-14 ADGM 5.4%≈ $785.5k -0.3 pts 13G 2026-08-14
JATT II ACQUISITION CORP JATT · 13G · filed 2026-08-14 JATT 5.4%≈ $4.7m new 13G 2026-08-14
REIN THERAPEUTICS INC RNTX · 13G · filed 2026-08-14 RNTX 5.3%≈ $4.7m new 13G 2026-08-14

Trades reported as a company insider since 1 Apr 2026

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2026-09-16 INMED PHARMACEUTICALS INC 10% owner · See Footnote INM Bought 8,340 $10.8k8.3k shares +1%
2026-09-15 INMED PHARMACEUTICALS INC 10% owner · See Footnote INM Bought 54,256 $70.5k54.3k shares +6%
2026-09-14 INMED PHARMACEUTICALS INC 10% owner · See Footnote INM Bought 28,505 $36.8k28.5k shares +4%
2026-09-03 TENAX THERAPEUTICS INC 10% owner · See Footnote TENX Bought 900,000 —900.0k shares +16%
2026-09-02 TENAX THERAPEUTICS INC 10% owner · See Footnote TENX Bought 187,704 —187.7k shares +4%
2026-09-01 TENAX THERAPEUTICS INC 10% owner · See Footnote TENX Bought 179,058 —179.1k shares +3%
2026-08-31 TENAX THERAPEUTICS INC 10% owner · See Footnote TENX Bought 403,571 —403.6k shares +8%
2026-08-24 TENAX THERAPEUTICS INC 10% owner · See Footnote TENX Bought 107,374 —107.4k shares +2%
2026-08-21 TENAX THERAPEUTICS INC 10% owner · See Footnote TENX Bought 716,369 —716.4k shares +18%
2026-08-20 TENAX THERAPEUTICS INC 10% owner · See Footnote TENX Bought 202,124 —202.1k shares +5%
2026-07-31 NEXTCURE INC 10% owner · See Footnote NXTC Bought 36,303 $179.3k36.3k shares +5%
2026-07-30 NEXTCURE INC 10% owner · See Footnote NXTC Bought 292,850 $1.4m292.9k shares +74%
2026-07-29 NEXTCURE INC 10% owner · See Footnote NXTC Bought 3,410 $17.1k3.4k shares +1%
2026-07-28 NEXTCURE INC 10% owner · See Footnote NXTC Bought 6,400 $31.7k6.4k shares +2%
2026-07-27 NEXTCURE INC 10% owner · See Footnote NXTC Bought 7,798 $39.0k7.8k shares +2%
2026-07-15 INMED PHARMACEUTICALS INC 10% owner · See Footnote INM Bought 1,000 $1.6k1.0k shares +<1%
2026-05-19 INMED PHARMACEUTICALS INC 10% owner · See Footnote INM Bought 468,551 $721.7k468.6k shares +141%
2026-05-19 RALLYBIO CORP 10% owner · See Footnote RLYB Bought 10,200 $142.6k10.2k shares +1%
2026-05-18 RALLYBIO CORP 10% owner · See Footnote RLYB Bought 6,009 $84.0k6.0k shares +1%
2026-05-15 RALLYBIO CORP 10% owner · See Footnote RLYB Bought 300 $4.2k300 shares +<1%
2026-05-13 RALLYBIO CORP 10% owner · See Footnote RLYB Bought 79,259 $1.1m79.3k shares +10%
2026-05-12 RALLYBIO CORP 10% owner · See Footnote RLYB Bought 800 $11.1k800 shares +<1%
2026-05-11 RALLYBIO CORP 10% owner · See Footnote RLYB Bought 50,000 $700.0k50.0k shares +6%
2026-05-05 RALLYBIO CORP 10% owner · See Footnote RLYB Bought 35,101 $491.4k35.1k shares +5%
2026-05-04 RALLYBIO CORP 10% owner · See Footnote RLYB Bought 120,804 $1.7m120.8k shares +19%